{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:36:27Z","timestamp":1792708587921,"version":"4.5.0"},"reference-count":30,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"DOI":"10.2340\/actadv.v105.42177","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:41:18Z","timestamp":1738762878000},"page":"adv42177","source":"Crossref","is-referenced-by-count":2,"title":["Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis"],"prefix":"10.2340","volume":"105","author":[{"given":"Hanna","family":"Schratter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Graier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Legat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Hofmann-Wellenhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"93478","doi-asserted-by":"crossref","unstructured":"Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, K\u00f6ks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol 2017; 31: 1792-1799.","DOI":"10.1111\/jdv.14386"},{"key":"93479","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.14386","DOI":"10.1111\/jdv.14386"},{"key":"93480","doi-asserted-by":"crossref","unstructured":"Marrakchi S, Puig L. Pathophysiology of generalized pustular psoriasis. Am J Clin Dermatol 2022; 23: 13-19.","DOI":"10.1007\/s40257-021-00655-y"},{"key":"93481","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s40257-021-00655-y","DOI":"10.1007\/s40257-021-00655-y"},{"key":"93482","doi-asserted-by":"crossref","unstructured":"Bachelez H, Barker J, Burden AD, Navarini AA, Krueger JG. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Rev Clin Immunol 2022; 18: 1033-1047.","DOI":"10.1080\/1744666X.2022.2116003"},{"key":"93483","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/1744666X.2022.2116003","DOI":"10.1080\/1744666X.2022.2116003"},{"key":"93484","doi-asserted-by":"crossref","unstructured":"Wolf P, Ceovic R, Conrad C, Falkensteiner K, Graier T, Ko\u0142t-Kami\u0144ska M, et al. Characteris-tics and management of generalized pustular psoriasis (GPP): Experience from the central and eastern Europe (CEE) GPP Expert Network. J Eur Acad Dermatol Venereol 2024; 38: 1531-1542.","DOI":"10.1111\/jdv.19808"},{"key":"93485","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.19808","DOI":"10.1111\/jdv.19808"},{"key":"93486","doi-asserted-by":"crossref","unstructured":"Boehner A, Navarini AA, Eyerich K. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review. Exp Dermatol 2018; 27: 1067-1077.","DOI":"10.1111\/exd.13699"},{"key":"93487","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/exd.13699","DOI":"10.1111\/exd.13699"},{"key":"93488","doi-asserted-by":"crossref","unstructured":"Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis. N Engl J Med 2019; 380: 981-983.","DOI":"10.1056\/NEJMc1811317"},{"key":"93489","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMc1811317","DOI":"10.1056\/NEJMc1811317"},{"key":"93490","doi-asserted-by":"crossref","unstructured":"Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, et al. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med 2021; 385: 2431-2440.","DOI":"10.1056\/NEJMoa2111563"},{"key":"93491","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa2111563","DOI":"10.1056\/NEJMoa2111563"},{"key":"93492","doi-asserted-by":"crossref","unstructured":"Blair HA. Spesolimab: First Approval. Drugs 2022; 82: 1681-1686.","DOI":"10.1007\/s40265-022-01801-4"},{"key":"93493","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s40265-022-01801-4","DOI":"10.1007\/s40265-022-01801-4"},{"key":"93494","doi-asserted-by":"crossref","unstructured":"Russo G, Dumont S, Menzinger S, Pastor D, Toutous Trellu L, Kaya G, et al. Severe acute generalized exanthematous pustulosis successfully treated by spesolimab. Acta Derm Venereol 2024; 104: adv41311.","DOI":"10.2340\/actadv.v104.41311"},{"key":"93495","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/actadv.v104.41311","DOI":"10.2340\/actadv.v104.41311"},{"key":"93496","doi-asserted-by":"crossref","unstructured":"Belvisi V, Orsi GB, Del Borgo C, Fabietti P, Ianari A, Albertoni F, et al. Large nosocomial outbreak associated with a Norwegian scabies index case undergoing TNF-\u03b1 inhibitor treatment: management and control. Infect Control Hosp Epidemiol 2015; 36: 1358-1360.","DOI":"10.1017\/ice.2015.188"},{"key":"93497","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1017\/ice.2015.188","DOI":"10.1017\/ice.2015.188"},{"key":"93498","doi-asserted-by":"crossref","unstructured":"Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol 2017; 31: 1248-1253.","DOI":"10.1111\/jdv.14351"},{"key":"93499","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.14351","DOI":"10.1111\/jdv.14351"},{"key":"93500","doi-asserted-by":"crossref","unstructured":"Alabbadi A, Alalwi S, Alkhalifah R, Alfaraj D, Albreiki S, Bin Rubaian N, et al. Scabies-associated leukocytoclastic vasculitis: A case report and review of literature. Cureus 2021; 13: e20725.","DOI":"10.7759\/cureus.20725"},{"key":"93501","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7759\/cureus.20725","DOI":"10.7759\/cureus.20725"},{"key":"93502","doi-asserted-by":"crossref","unstructured":"Chung SD, Lin HC, Wang KH. Increased risk of pemphigoid following scabies: a population-based matched-cohort study. J Eur Acad Dermatol Venereol 2014; 28: 558-564.","DOI":"10.1111\/jdv.12132"},{"key":"93503","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.12132","DOI":"10.1111\/jdv.12132"},{"key":"93504","doi-asserted-by":"crossref","unstructured":"Pipitone MA, Adams B, Sheth A, Graham TB. Crusted scabies in a patient being treated with infliximab for juvenile rheumatoid arthritis. J Am Acad Dermatol 2005; 52: 719-720.","DOI":"10.1016\/j.jaad.2004.12.039"},{"key":"93505","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2004.12.039","DOI":"10.1016\/j.jaad.2004.12.039"},{"key":"93506","doi-asserted-by":"crossref","unstructured":"Saillard C, Darrieux L, Safa G. Crusted scabies complicates etanercept therapy in a patient with severe psoriasis. J Am Acad Dermatol 2013; 68: e138-e139.","DOI":"10.1016\/j.jaad.2012.09.049"},{"key":"93507","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2012.09.049","DOI":"10.1016\/j.jaad.2012.09.049"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/42177\/49015","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/42177\/49015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:41:28Z","timestamp":1738762888000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/42177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2340\/actadv.v105.42177","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}